Net profit of Natco Pharma declined 28.09% to Rs 480.70 crore in the quarter ended June 2025 as against Rs 668.50 crore during the previous quarter ended June 2024. Sales declined 2.47% to Rs 1328.90 crore in the quarter ended June 2025 as against Rs 1362.60 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
| Sales | 1328.90 | 1362.60 | -2 |
| OPM % | 42.97 | 59.06 | - |
| PBDT | 629.50 | 847.70 | -26 |
| PBT | 571.90 | 803.60 | -29 |
| NP | 480.70 | 668.50 | -28 |